Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.

Abstract

Motivated from the shortage of the existing research studies on impacts of dangerously contagious diseases on firms’ financial performance, this study sheds light on the impacts of Coronavirus (Covid-19) outbreak on financial performance upon on the quarterly data of 126 Chinese listed firms across 16 industries. Overall, the Covid-19 outbreak reduced Chinese listed firms’ financial performance proxied by the revenue growth rate, ROA, ROE, and asset turnover. This outbreak’s negative effects on Chinese firms’ profitability were much smaller than that on their revenue growth rates. While this outbreak’s negative effects on financial performance of Chinese listed firms were bigger for those that were seriously affected by this pandemic like airlines, travel, and entertainment (ATE), this pandemic’s effects were positive for the medicine industry. In the meanwhile, Chinese listed firms that located in high-risk regions suffered a bigger financial loss during the outbreak, and especially there was a strong Hubei effect. The corporate culture and CSR moderated the inverse relationship between this outbreak and Chinese firms’ financial performance. Findings of this study contribute to enrich the existing literature on impacts of the Covid-19 outbreak on firms’ financial performance worldwide and suggest helpful practical and theoretical implications.